Skip to main content

Table 2 Allelic distribution of HLA-C in patients and controls

From: HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis

HLA-C allele

Psoriasis (n = 45)

PsA (n = 100)

Controls (n = 177)

Cw*0102

5 (11)

10 (10)

13 (7)

Cw*0202

4 (9)

8 (8)

9 (5)

Cw*0303

3 (7)

11 (11)

19 (11)

Cw*0304

2 (4)

4 (4)

15 (8)

Cw*0401

7 (15)

23 (23)

50 (28)

Cw*0501

4 (9)

9 (9)

30 (17)

Cw*0602

26 (58)a

58 (58)b

32 (18)

Cw*0701

9 (20)

19 (19)c

54 (31)

Cw*0702

7 (15)

17 (17)

45 (25)

Cw*0802

2 (4)

3 (3)d

17 (10)

Cw*1203

3 (7)

3 (3)

6 (3)

Cw*1402

1 (2)

4 (4)

9 (5)

Cw*1502

4 (9)

5 (5)

13 (7)

Cw*1601

2 (4)

4 (4)

15 (8)

Cw*1602

-

-

2 (1)

  1. HLA, human leukocyte antigen; PsA, psoriatic arthritis. Results in parentheses are percentages. aOdds ratio (OR) 6.2 (95% confidence interval (CI) 3.1 to 12.5; p < 0.0001); bOR 6.2 (95% CI 3.6 to 10.8; p < 0.0001); cOR 0.5 (95% CI 0.3 to 0.9; p = 0.04); dOR 0.3 (95% CI 0.08 to 1.00; p = 0.05).